Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.
2023
Brusson M et Al.
Molecular therapy Nucleic acids 32, 229-246.
2023
Brusson M et Al.
Molecular therapy Nucleic acids 32, 229-246.